article thumbnail

Pharma must embrace an AI future says new report

Drug Discovery World

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com. The report points towards inorganic strategies amongst market players that are boosting AI in drug discovery.

article thumbnail

How AI in pharma can live up to the hype 

Drug Discovery World

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. According to Hampleton Patners’ latest Healthtech M&A market report2, digital health companies raised a total of $57.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit

Alta Sciences

Watch Altasciences in "Flipping the Drug Development Industry on Its Head" A Brief History of the CRO Market Contract Research Organizations (CROs) first entered the pharma world in the 1970s. CROs have historically functioned as auxiliaries to pharma companies, conducting the work sponsors can’t do in-house.

article thumbnail

India: Why is the country ramping up drug discovery research?

Drug Discovery World

In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. A report by PWC shared that the pharmaceutical industry’s main markets are under ‘serious pressure’ 7.

Research 130